ARCHIVES

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

PCI Files Application For Research Base COP

September 9, 1994

Bosnian Research Trying To Leave, Asks For More Calls

February 5, 1993

In Brief: Capp Heads Roentgen Ray Society; Annual Lecture, Chair Honors Charles Spurr

June 22, 1990

U.S. Cancer Mortality Declines Overall; Incidence, Death, For 12 Cancers Rising

June 8, 2001

IOM Omics Committee Offers Blueprint to Prevent Other Duke-Style Disasters

March 23, 2012

Maria Carolina Hinestrosa, EVP of National Breast Cancer Coalition

June 26, 2009